Maternal transfer or referral to a health facility · pregnant women giving birth in non‐facility settings
Prophylactic oxytocin injection (delivered by community health… showed no clear difference in transfer or referral to health facility [ compared with control (no injection) (low certainty).
1 finding from 1 review
Stillbirth · pregnant women giving birth in non‐facility settings
Prophylactic oxytocin injection (delivered by community health… showed no clear difference in stillbirths [ compared with control (no injection) (low certainty).
1 finding from 1 review
Early infant death (0‐3 days) [ · pregnant women giving birth in non‐facility settings
Prophylactic oxytocin injection (delivered by community health… showed no clear difference in early infant death (0‐3 days) [ compared with control (no injection) (low certainty).
1 finding from 1 review
Endometritis · pregnant women undergoing caesarean section
Intravenous route showed no clear difference in endometritis compared with irrigation (lavage) (low certainty).
1 finding from 1 review
Wound infection · pregnant women undergoing caesarean section
It is very uncertain whether intravenous route changes wound infection compared with irrigation (lavage) (very low certainty).
1 finding from 1 review
Febrile morbidity · pregnant women undergoing caesarean section
It is very uncertain whether intravenous route changes postpartum febrile morbidity compared with irrigation (lavage) (very low certainty).
1 finding from 1 review
Urinary tract infection · pregnant women undergoing caesarean section
It is very uncertain whether intravenous route changes urinary tract infection compared with irrigation (lavage) (very low certainty).
1 finding from 1 review
Serious infectious complications · pregnant women undergoing caesarean section
1 finding from 1 review
Maternal adverse events · pregnant women undergoing caesarean section
1 finding from 1 review
Infant sepsis (suspected or proven) ‐ not measured · pregnant women undergoing caesarean section
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Large‐for‐gestational age · women with gestational diabetes mellitus
Myo‐inositol showed no clear difference in large‐for‐gestational age compared with placebo (low certainty).
1 finding from 1 review
Induction of labour · women with gestational diabetes mellitus
1 finding from 1 review
Perineal trauma · women with gestational diabetes mellitus
1 finding from 1 review
Development of type 2 diabetes · women with gestational diabetes mellitus
1 finding from 1 review
Perinatal mortality · women with gestational diabetes mellitus
1 finding from 1 review
Neonatal hypoglycaemia · women with gestational diabetes mellitus
Myo‐inositol may leads to lower neonatal hypoglycaemia compared with placebo (low certainty).
1 finding from 1 review
Composite of serious neonatal outcomes · women with gestational diabetes mellitus
1 finding from 1 review
Childhood/adulthood adiposity · women with gestational diabetes mellitus
1 finding from 1 review
Childhood/adulthood diabetes · women with gestational diabetes mellitus
1 finding from 1 review
Neurosensory disability · women with gestational diabetes mellitus
1 finding from 1 review